Navigation Links
Susan G. Komen for the Cure(R)'s Circle of Promise Welcomes Gabrielle Union, Lalah Hathaway, Synthia SAINT JAMES as National Ambassadors
Date:5/29/2008

t to know the facts. We're our own best health advocates."

Union has two upcoming movies, "Meet Dave" co-starring Eddie Murphy, and "Cadillac Records" co-starring Beyonce Knowles.

Lalah Hathaway

The daughter of Donny Hathaway, one of the most influential soul artists of the 1970s, Lalah Hathaway is respected in her own right. She has developed a reputation as an artist with a unique and timeless sound, and as a gifted lyricist, who is emotionally in tune with women from all backgrounds.

"The rate of Black women and girls diagnosed with breast cancer is rising at an alarming rate," said Hathaway. "We are fighting a common enemy. Knowledge and having a take-charge mindset and attitude are critical weapons in the fight against this deadly disease. I became active because I want to be an ambassador of change. If I tell seven of my friends and they tell seven of their friends and so on, the circle will continue to expand and we'll create a chorus of voices within the African-American community to eradicate breast cancer. I truly believe that this is a goal we can achieve together."

Hathaway's 4th solo album, "Self Portrait," will be released June 3rd on the Stax Records/Concord Music Group label.

Synthia SAINT JAMES

Synthia SAINT JAMES is a multiple award winning artist, architectural designer, speaker, author and songwriter and now a Circle of Promise ambassador. She has gained international recognition for her work. She travels the world, inspiring people through speaking engagements, exhibitions, and unveilings.

"I am pledging to tell everyone I can to sign up for Circle of Promise and I plan to use the opportunities afforded me to raise awareness and money for this cause. By working with Susan G. Komen for the Cure, I am joining millions of survivors and activists around the globe in raising our voices against this disease."

SAINT JAMES' latest achievement is a signature painting for the Circle of Promise
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Susan G. Komen for the Cure(R) Celebrity Ambassadors to Convene in Nations Capital to Help Race for the Cure, End Breast Cancer Forever
2. Susan G. Komen for the Cure(R) Encourages Nation to Go Passionately Pink by Donning Pink, Donating Funds to End Breast Cancer Forever
3. Saia Partners with Susan G. Komen for the Cure
4. Susan G. Komen for the Cures(R) Moddelmog Calls for Congress to Launch Colossal Cancer Crusade
5. Great Mothers Day Gift - Supporting Susan G. Komen for the Cure
6. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
7. Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position
8. Susan Powter The Politics of Stupid: The Cure for Obesity
9. Cynthia Nixon to Serve as Ambassador for Susan G. Komen for the Cure(R)
10. Susan G. Komen for the Cure(R) Calls on Policymakers to Address Unfairness in Breast Cancer Incidence and Mortality
11. Massachusetts Affiliate of Susan G. Komen for the Cure(R) to Challenge States Leaders to Strengthen Breast Cancer Services
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Americans United for Life Condemns Ruling Increasing Minors' Access to Dangerous Plan B 2Health News:AANS President to Testify on Patient Access to Care 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 3Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 4Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 5Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 6Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 7Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 8Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 9Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 10Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 11Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 12Health News:Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultz's 'The Early Act' 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 3
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 1Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 2Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 3Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 1Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 3SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 1SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 2SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 3